“…The histamine H1-receptor V, named astemizloe, [5] and bioactive com-pounds VI and VI' [6] all contain the 2-aminobenzimidazole skeleton.There are several reported approaches to these scaffolds: 1) The addition of amines to isothiocyanates or CS 2 followed by intramolecular condensation, [7,8] 2) the cross-coupling reaction of bisnucleophiles with cyanogen bromide, [9] 3) intramolecular cyclization by C À H activation, [10] and 4) passing through the intermediate formation of isocyanide dibromides. [11] All these procedures suffer from the use of unenviromental, toxic, and/or dangerous reagents and poor step efficiency. Thus, the development of a new, general, and atom-economic method to obtain these compounds remains great challenge to chemists.Recently, reactions using isocyanide insertion (similar to carbon monoxide) have been developed for the synthesis of N-heterocycles .[12] As a continuation of our work on the insertion of isocyanide into an active NÀH bond, [13] we hope to apply this insertion strategy to the reaction of isocyanide with À SH, [14] À OH, [15] and À NH 2 [16] based bisnucleophilic reagents, such as o-aminophenols, o-aminobenzenethiol, and o-aminoanilines, for the synthesis of 2-aminobenzimidazoles, 2-aminobenzothiazoles, and 2-aminobenzoxazoles, respectively (Scheme 1).…”